DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

22.81 -0.14 (-0.61%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AEGR $22.81 -0.61%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $22.92
Previous Close $22.95
Daily Range $22.48 - $23.57
52-Week Range $19.10 - $74.58
Market Cap $648.6M
P/E Ratio -14.90
Dividend (Yield) $0.00 (0.0%)
Volume 1,458,789
Average Daily Volume 871,181
Current FY EPS -$1.16

Sector

Healthcare

Industry

Drugs

Aegerion Pharmaceuticals, Inc. (AEGR) Description

Aegerion Pharmaceuticals, Inc. Website: http://www.aegerion.com/

News & Commentary Rss Feed

Why Aegerion Pharmaceuticals, Inc. Stock Collapsed in October

Aegerion Pharmaceuticals is October's worst biotech stock after reporting weaker-than-expected third-quarter results. Find out whether this dip is a buying opportunity or a warning sign of more weakness to come.

11.1% of XBI Holdings Seeing Recent Insider Buys

AEGR: Insiders Vs. Shorts

Nominees for Absolute Worst Bio-Technology CEOs of 2014 Are ...

Aegerion's Current Valuations Demand Attention

Gilead Sciences Releases Impressive Results for Hepatitis C Drug

Aegerion to Acquire Myalept, Boost Portfolio - Shares Up - Analyst Blog

AstraZeneca (AZN) Misses on Q3 Earnings, Raises Guidance - Analyst Blog

Commit To Buy Aegerion Pharmaceuticals At $15, Earn 17% Using Options

AstraZeneca Sells Myalept to Aegerion for $325 Million Upfront

See More AEGR News...

AEGR's Top Competitors

AEGR $22.81 (-0.61%)
Current stock: AEGR
JNJ $105.55 (-1.18%)
Current stock: JNJ
NVS $94.61 (0.04%)
Current stock: NVS
RHHBY $34.47 (-6.59%)
Current stock: RHHBY